Anti-S22A6/ SLC22A6/ HOAT1 monoclonal antibody

Anti-S22A6/ SLC22A6/ HOAT1 antibody for FACS & in-vivo assay

Target products collectionGo to SLC22A6/SLC22A6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1565-Ab-1/ GM-Tg-hg-MP1565-Ab-2Anti-Human SLC22A6 monoclonal antibodyHuman
GM-Tg-rg-MP1565-Ab-1/ GM-Tg-rg-MP1565-Ab-2Anti-Rat SLC22A6 monoclonal antibodyRat
GM-Tg-mg-MP1565-Ab-1/ GM-Tg-mg-MP1565-Ab-2Anti-Mouse SLC22A6 monoclonal antibodyMouse
GM-Tg-cynog-MP1565-Ab-1/ GM-Tg-cynog-MP1565-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC22A6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1565-Ab-1/ GM-Tg-felg-MP1565-Ab-2Anti-Feline SLC22A6 monoclonal antibodyFeline
GM-Tg-cang-MP1565-Ab-1/ GM-Tg-cang-MP1565-Ab-2Anti-Canine SLC22A6 monoclonal antibodyCanine
GM-Tg-bovg-MP1565-Ab-1/ GM-Tg-bovg-MP1565-Ab-2Anti-Bovine SLC22A6 monoclonal antibodyBovine
GM-Tg-equg-MP1565-Ab-1/ GM-Tg-equg-MP1565-Ab-2Anti-Equine SLC22A6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1565-Ab-1/ GM-Tg-hg-MP1565-Ab-2; GM-Tg-rg-MP1565-Ab-1/ GM-Tg-rg-MP1565-Ab-2;
GM-Tg-mg-MP1565-Ab-1/ GM-Tg-mg-MP1565-Ab-2; GM-Tg-cynog-MP1565-Ab-1/ GM-Tg-cynog-MP1565-Ab-2;
GM-Tg-felg-MP1565-Ab-1/ GM-Tg-felg-MP1565-Ab-2; GM-Tg-cang-MP1565-Ab-1/ GM-Tg-cang-MP1565-Ab-2;
GM-Tg-bovg-MP1565-Ab-1/ GM-Tg-bovg-MP1565-Ab-2; GM-Tg-equg-MP1565-Ab-1/ GM-Tg-equg-MP1565-Ab-2
Products NameAnti-SLC22A6 monoclonal antibody
Formatmab
Target NameSLC22A6
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC22A6 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species S22A6/ SLC22A6/ HOAT1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLV000232human SLC22A6 Lentivirus plasmid
    ORF Viral VectorvGMLV000232human SLC22A6 Lentivirus particle
    ORF Viral VectorpGMLPm004717mouse Slc22a6 Lentivirus plasmid
    ORF Viral VectorvGMLPm004717mouse Slc22a6 Lentivirus particle


    Target information

    Target IDGM-MP1565
    Target NameSLC22A6
    Gene ID9356,18399,29509,718377,476050,101094048
    Gene Symbol and SynonymsHOAT1,mOat1,NKT,OAT1,Orctl1,PAHT,ROAT1,SLC22A6
    Uniprot AccessionQ4U2R8,O35956
    Uniprot Entry NameS22A6_HUMAN,S22A6_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000197901
    Target ClassificationN/A

    The target: SLC22A6, gene name: SLC22A6, also named as HOAT1, OAT1, PAHT, ROAT1. The protein encoded by this gene is involved in the sodium-dependent transport and excretion of organic anions, some of which are potentially toxic. The encoded protein is an integral membrane protein and may be localized to the basolateral membrane. Four transcript variants encoding four different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.